Developmental strategy for a new Group A meningococcal conjugate vaccine (MenAfriVacR)
Until recently, periodic Group A meningococcal meningitis outbreaks were a major public health problem in the sub-Saharan Africa. In 2001, the Meningitis Vaccine Project (MVP), a partnership between the World Health Organization (WHO) and PATH, a Seattle-based NGO, and the Serum Institute of India P...
Saved in:
Main Authors: | Prasad S. Kulkarni (Author), Suresh S. Jadhav (Author), F. Marc LaForce (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps
by: F. Marc LaForce, et al.
Published: (2018) -
The impact of meningococcal conjugate vaccine (MenACWY-TT) on meningococcal carriage in Hajj Pilgrims returning to Turkey
by: Hasan Tezer, et al.
Published: (2020) -
Mapping Africa's advanced public health education capacity: the AfriHealth project
by: CB IJsselmuiden, et al.
Published: (2007) -
Using the tetravalent meningococcal polysaccharide-protein conjugate vaccine in the prevention of meningococcal disease
by: Sanford R Kimmel
Published: (2008) -
Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy meningococcal vaccine-naïve toddlers: A randomised, controlled trial
by: Markus Knuf, et al.
Published: (2022)